Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters

Schwab N, Schneider-Hohendorf T, Hoyt T, Gross CC, Meuth SG, Klotz L, Foley JF, Wiendl H

Research article (journal) | Peer reviewed

Details about the publication

Volume24
Issue5
Page range563-573
StatusPublished
Release year2017
Language in which the publication is writtenEnglish

Authors from the University of Münster

Groß, Catharina
Klotz, Luisa Hildegard
Meuth, Sven
Schneider-Hohendorf, Tilman
Schwab, Nicholas Christopher
Wiendl, Heinz Siegfried